{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:18:25Z","timestamp":1793222305218,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["25K18923"],"award-info":[{"award-number":["25K18923"]}]},{"name":"JSPS KAKENHI","award":["22KK0108"],"award-info":[{"award-number":["22KK0108"]}]},{"name":"JSPS KAKENHI","award":["22H04961"],"award-info":[{"award-number":["22H04961"]}]},{"name":"F-REI","award":["JPFR2504030"],"award-info":[{"award-number":["JPFR2504030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46505-x","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:05:20Z","timestamp":1778576720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tellurium-118 as a novel radionuclide for long-term positron emission tomography"],"prefix":"10.1038","volume":"16","author":[{"given":"Sotaro","family":"Miyao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Mitsuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko Nakanishi","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Haba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi O.","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Akimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"46505_CR1","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/cncr.28860","volume":"120","author":"MD Farwell","year":"2014","unstructured":"Farwell, M. D., Pryma, D. A. & Mankoff, D. A. PET\/CT imaging in cancer: Current applications and future directions. Cancer 120, 3433\u20133445 (2014).","journal-title":"Cancer"},{"key":"46505_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41568-023-00576-4","volume":"23","author":"J Schwenck","year":"2023","unstructured":"Schwenck, J. et al. Advances in PET imaging of cancer. Nat. Rev. Cancer 23, 547\u2013566 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"46505_CR3","doi-asserted-by":"publisher","first-page":"102940","DOI":"10.1016\/j.ctrv.2025.102940","volume":"118","author":"F Giugliano","year":"2025","unstructured":"Giugliano, F. et al. Radioligand therapy in metastatic breast cancer: Harnessing precision oncology. Cancer Treat. Rev. 118, 102940 (2025).","journal-title":"Cancer Treat. Rev."},{"key":"46505_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.nucmedbio.2007.03.007","volume":"34","author":"MR Zalutsky","year":"2007","unstructured":"Zalutsky, M. R. et al. Targeted \u03b1-particle radiotherapy with 211At-labeled monoclonal antibodies. Nucl. Med. Biol. 34, 779\u2013785 (2007).","journal-title":"Nucl. Med. Biol."},{"key":"46505_CR5","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2967\/jnumed.120.248062","volume":"61","author":"TG Chan","year":"2020","unstructured":"Chan, T. G., O\u2019Neill, E., Habjan, C. & Cornelissen, B. Combination strategies to improve targeted radionuclide therapy. J. Nucl. Med. 61, 1544\u20131552 (2020).","journal-title":"J. Nucl. Med."},{"key":"46505_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020205","volume":"12","author":"R Danieli","year":"2022","unstructured":"Danieli, R. et al. Personalized dosimetry in targeted radiation therapy: A look to methods, tools and critical aspects. J. Pers. Med. 12, 205 (2022).","journal-title":"J. Pers. Med."},{"key":"46505_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/clpt.2008.170","volume":"84","author":"W Wang","year":"2008","unstructured":"Wang, W. et al. Monoclonal antibodies: pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 84, 548\u2013558 (2008).","journal-title":"Clin. Pharmacol. Ther."},{"key":"46505_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-022-00507-w","volume":"22","author":"J van Sluis","year":"2022","unstructured":"van Sluis, J. et al. Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high-sensitivity PET\/CT. Cancer Imaging 22, 69 (2022).","journal-title":"Cancer Imaging"},{"key":"46505_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nucmedbio.2021.12.003","volume":"106\u2013107","author":"R Imura","year":"2022","unstructured":"Imura, R. et al. Radiolabeling of PSMA-617 with 89Zr: a novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results. Nucl. Med. Biol. 106\u2013107, 21\u201328 (2022).","journal-title":"Nucl. Med. Biol."},{"key":"46505_CR10","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.bioconjchem.4c00274","volume":"35","author":"R Imura","year":"2024","unstructured":"Imura, R. et al. Click chemistry enables [89Zr] Zr-DOTA radioimmunoconjugation for theranostic 89Zr-immunoPET. Bioconjug. Chem. 35, 1746\u20131755 (2024).","journal-title":"Bioconjug. Chem."},{"key":"46505_CR11","volume":"2014","author":"FCJ van de Watering","year":"2014","unstructured":"van de Watering, F. C. J. et al. Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients. Biomed. Res. Int. 2014, 203601 (2014).","journal-title":"Biomed. Res. Int."},{"key":"46505_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s11307-024-01948-4","volume":"26","author":"JM Omweri","year":"2024","unstructured":"Omweri, J. M. et al. Development of 52Mn labeled trastuzumab for extended time point PET imaging of HER2. Mol. Imaging Biol. 26, 858\u2013868 (2024).","journal-title":"Mol. Imaging Biol."},{"key":"46505_CR13","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s00259-023-06194-4","volume":"50","author":"J van Sluis","year":"2023","unstructured":"van Sluis, J. et al. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET\/CT. Eur. J. Nucl. Med. Mol. Imaging. 50, 2258\u20132270 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"46505_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00259-011-1768-2","volume":"38","author":"M Lubberink","year":"2011","unstructured":"Lubberink, M. & Herzog, H. Quantitative imaging of 124I and 86Y with PET. Eur. J. Nucl. Med. Mol. Imaging. 38, 10\u201318 (2011).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"suppl. 1","key":"46505_CR15","first-page":"252001","volume":"66","author":"S Samuel","year":"2025","unstructured":"Samuel, S. et al. Characterization of unique radionuclides on a preclinical PET scanner. J. Nucl. Med. 66 (suppl. 1), 252001 (2025).","journal-title":"J. Nucl. Med."},{"key":"46505_CR16","first-page":"1","volume":"80","author":"Health Canada","year":"2024","unstructured":"Health Canada. Guidelines for Canadian drinking water quality: Guideline technical document \u2013 Antimony. Health Can. 80, 1\u201380 (2024).","journal-title":"Health Can."},{"key":"46505_CR17","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1039\/c0ob00086h","volume":"8","author":"LA Ba","year":"2010","unstructured":"Ba, L. A. et al. Tellurium: An element with great biological potency and potential. Org. Biomol. Chem. 8, 4203\u20134216 (2010).","journal-title":"Org. Biomol. Chem."},{"key":"46505_CR18","doi-asserted-by":"crossref","unstructured":"Yano, Y. & Anger, H. O. Tellurium-118\/antimony-118 generator. Conf. Proc. Soc. Nucl. Med. (1989).","DOI":"10.1017\/S0308229600011089"},{"key":"46505_CR19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/cbdd.14311","volume":"102","author":"M Hassan","year":"2023","unstructured":"Hassan, M., Bokhari, T. H., Lodhi, N. A., Khosa, M. K. & Usman, M. A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes. Chem. Biol. Drug Des. 102, 935\u2013957 (2023).","journal-title":"Chem. Biol. Drug Des."},{"key":"46505_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3892\/etm.2024.12514","volume":"27","author":"T Niu","year":"2024","unstructured":"Niu, T. et al. Current clinical application of lutetium\u2013177 in solid tumors. Exp. Ther. Med. 27, 225 (2024).","journal-title":"Exp. Ther. Med."},{"key":"46505_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2967\/jnumed.124.268805","volume":"66","author":"E Rioja-Blanco","year":"2025","unstructured":"Rioja-Blanco, E. et al. 161\u00a0Tb radioimmunotherapy as a treatment for CD30-positive lymphomas. J. Nucl. Med. 66, 909\u2013915 (2025).","journal-title":"J. Nucl. Med."},{"key":"46505_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-023-00589-w","volume":"10","author":"FA Verburg","year":"2023","unstructured":"Verburg, F. A., de Blois, E., Koolen, S. & Konijnenberg, M. W. Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: Potential dosimetric implications for activity selection. EJNMMI Phys. 10, 69 (2023).","journal-title":"EJNMMI Phys."},{"key":"46505_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.7150\/thno.92273","volume":"14","author":"A Schaefer-Schuler","year":"2024","unstructured":"Schaefer-Schuler, A. et al. [161\u00a0Tb] Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu] Lu-PSMA-617. Theranostics 14, 1829\u20131840 (2024).","journal-title":"Theranostics"},{"key":"46505_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2967\/jnumed.116.177857","volume":"58","author":"CG England","year":"2017","unstructured":"England, C. G. et al. Preclinical pharmacokinetics and biodistribution studies of 89Zr\u2013labeled pembrolizumab. J. Nucl. Med. 58, 162\u2013168 (2017).","journal-title":"J. Nucl. Med."},{"key":"46505_CR25","doi-asserted-by":"publisher","first-page":"741855","DOI":"10.3389\/fmed.2021.741855","volume":"8","author":"A Krache","year":"2022","unstructured":"Krache, A. et al. Preclinical pharmacokinetics and dosimetry of an 89Zr\u2013labelled anti\u2013PD\u2013L1 antibody in an orthotopic lung cancer murine model. Front. Med. (Lausanne). 8, 741855 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"46505_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu, L. Pharmacokinetics of monoclonal antibodies and Fc\u2011fusion proteins. Protein Cell 9, 15\u201332 (2018).","journal-title":"Protein Cell"},{"key":"46505_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/2197-7364-1-S1-A50","volume":"1","author":"A Eleftheriou","year":"2014","unstructured":"Eleftheriou, A., Tsoumpas, C., Bertolli, O. & Stiliaris, E. Effect of the magnetic field on positron range using GATE for PET-MR. EJNMMI Phys. 1, A50 (2014).","journal-title":"EJNMMI Phys."},{"issue":"11","key":"46505_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1140\/epjp\/i2017-11779-x","volume":"132","author":"C Li","year":"2017","unstructured":"Li, C. et al. Compressive effect of the magnetic field on the positron range in commonly used positron emitters simulated using Geant4. Eur. Phys. J. Plus 132484. (2017).","journal-title":"Eur. Phys. J. Plus"},{"key":"46505_CR29","first-page":"507","volume":"13","author":"EM Banoqitah","year":"2020","unstructured":"Banoqitah, E. M. et al. A modified semi-empirical formula to calculate the maximum positron range affected by different magnetic field strengths for PET\/MRI scanner. J. Radiat. Res. Appl. Sci. 13, 507\u2013514 (2020).","journal-title":"J. Radiat. Res. Appl. Sci."},{"key":"46505_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095250","volume":"9","author":"NJ Shah","year":"2014","unstructured":"Shah, N. J. et al. Effects of magnetic fields of up to 9.4 T on resolution and contrast of PET images as measured with an MR-BrainPET. PLoS ONE 9, e95250 (2014).","journal-title":"PLoS ONE"},{"key":"46505_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0039-9140(79)80191-5","volume":"26","author":"T Kamada","year":"1979","unstructured":"Kamada, T., Sugita, N. & Yamamoto, Y. Differential determination of tellurium(IV) and tellurium(VI) with sodium diethyldithiocarbamate, ammonium pyrrolidinedithiocarbamate and dithizone by atomic-absorption spectrophotometry with a carbon-tube atomizer. Talanta 26, 337\u2013340 (1979).","journal-title":"Talanta"},{"key":"46505_CR32","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00259-025-07103-7","volume":"52","author":"HH Tran","year":"2025","unstructured":"Tran, H. H., Yamaguchi, A. & Manning, H. C. Radiotheranostic landscape: A review of clinical and preclinical development. Eur. J. Nucl. Med. Mol. Imaging 52, 2685\u20132709 (2025).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"46505_CR33","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/0969-8043(94)90186-4","volume":"45","author":"SK Das","year":"1994","unstructured":"Das, S. K., Guin, R. & Saha, S. K. Separation of carrier-free tellurium from bulk amounts of tin. Appl. Radiat. Isot. 45, 1077\u20131078 (1994).","journal-title":"Appl. Radiat. Isot."},{"key":"46505_CR34","first-page":"195","volume":"53","author":"T Kubota","year":"2020","unstructured":"Kubota, T. et al. Separation of 121mTe from antimony without redox reaction. RIKEN Accel Prog Rep. 53, 195 (2020).","journal-title":"RIKEN Accel Prog Rep."},{"key":"46505_CR35","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"Percie du Sert","year":"2020","unstructured":"Percie du Sert. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).","journal-title":"PLoS Biol."},{"key":"46505_CR36","unstructured":"National Nuclear Data Center. NuDat 3.0. https:\/\/www.nndc.bnl.gov\/nudat3\/"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46505-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:05:26Z","timestamp":1778576726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46505-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46505"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46505-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13909"}}